PMID- 1423229 OWN - NLM STAT- MEDLINE DCOM- 19921222 LR - 20190815 IS - 0165-4608 (Print) IS - 0165-4608 (Linking) VI - 63 IP - 1 DP - 1992 Oct 1 TI - Application of fluorescence in situ hybridization in hematological disorders. PG - 62-9 AB - In the present study, chromosome changes in bone marrow (BM) or peripheral blood (PB) cells from 13 patients with malignant hematologic disorders were analyzed by classical cytogenetic techniques (G-banding) and fluorescence in situ hybridization (FISH) procedures using centromere specific probes for chromosomes 1, 6, 7, 8, 9, 12, 18, 13/21, and X, and a DNA probe specific for the long arm of chromosome Y. The cytogenetic data obtained with G-banding were in accord with those obtained by FISH to metaphase chromosomes. Most significantly, FISH to interphase nuclei offered reliable results and in some cases provided important information concerning crucial chromosome anomalies which were not or could not be completely detected by analyzing metaphase chromosomes. Our results indicate that FISH could be clinically valuable in five major areas: 1) marker chromosome identification; 2) identification of trisomy consistent with certain specific hematological neoplasms; 3) clonal evaluation post observation of a single cell with trisomy; 4) clonal evaluation post-sex-mismatched bone marrow transplantation (BMT); and 5) residual disease detection following clinical remission. FAU - Chen, Z AU - Chen Z AD - Cancer Center of Southwest Biomedical Research Institute and Genetrix, Inc., Scottsdale, Arizona 85251. FAU - Morgan, R AU - Morgan R FAU - Berger, C S AU - Berger CS FAU - Sandberg, A A AU - Sandberg AA LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Cancer Genet Cytogenet JT - Cancer genetics and cytogenetics JID - 7909240 RN - 0 (Biomarkers, Tumor) RN - 0 (DNA Probes) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Biomarkers, Tumor MH - Child, Preschool MH - DNA Probes MH - Evaluation Studies as Topic MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Leukemia/*genetics MH - Male MH - Middle Aged MH - Myelodysplastic Syndromes/*genetics MH - Sensitivity and Specificity MH - Severe Combined Immunodeficiency/*genetics EDAT- 1992/10/01 00:00 MHDA- 1992/10/01 00:01 CRDT- 1992/10/01 00:00 PHST- 1992/10/01 00:00 [pubmed] PHST- 1992/10/01 00:01 [medline] PHST- 1992/10/01 00:00 [entrez] AID - 0165-4608(92)90066-H [pii] AID - 10.1016/0165-4608(92)90066-h [doi] PST - ppublish SO - Cancer Genet Cytogenet. 1992 Oct 1;63(1):62-9. doi: 10.1016/0165-4608(92)90066-h.